Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses

References

• Burnouf T, Goubran HA, Chen TM, Ou KL, El-Ekiaby M, Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 2013;27: 77–89. Epub 2013/ 02/26. doi: 10.1016/j.blre.2013.02.001
   PubMed Web of Science ®Google Scholar
• De Pascale MR, Sommese L, Casamassimi A, Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev 2015;29: 52–61. Epub 2014/ 12/30. doi: 10.1016/j.tmrv.2014.11.001
   PubMed Web of Science ®Google Scholar
• Anitua E, Prado R, Orive G. Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy? Trends Biotechnol 2017;35: 91–93. Epub 2016/ 12/03. doi: 10.1016/j.tibtech.2016.11.001
   PubMed Web of Science ®Google Scholar
• Alsousou J, Harrison P. Therapeutic platelet-rich plasma in wound healing. Platelets. Academic press 2019:1161–1171 doi:10.1016/B978-0-12-813456-6.00065-5
   Google Scholar
• Burnouf T, Strunk D, Koh MB, Schallmoser K. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials 2016;76: 371–387. Epub 2015/ 11/13. doi: 10.1016/j.biomaterials.2015.10.065
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Henschler R, Gabriel C, Koh MBC, Burnouf T. Production and quality requirements of human platelet lysate: a position statement from the working party on cellular therapies of the international society of blood transfusion. Trends Biotechnol 2020;38(1): 13–23. Epub 2019/ 07/22. doi: 10.1016/j.tibtech.2019.06.002
   PubMed Web of Science ®Google Scholar
• Sell SA, Wolfe PS, Ericksen JJ, Simpson DG, Bowlin GL. Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications. Tissue Eng Part A 2011;17(21–22):2723–2737. doi: 10.1089/ten.tea.2010.0663
   PubMed Web of Science ®Google Scholar
• Geremicca W, Fonte C, Vecchio S. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms. Blood Transfusion 2010; 8:107
   PubMed Web of Science ®Google Scholar
• Fea AM, Aragno V, Testa V, Machetta F, Parisi S, D’Antico S, Spinetta R, Fusaro E, Grignolo FM. The effect of autologous platelet lysate eye drops: an in vivo confocal microscopy study. Biomed Res Int 2016;2016: 8406832. Epub 2016/ 05/21. doi: 10.1155/2016/8406832
   PubMed Web of Science ®Google Scholar
• Avila MY, Igua AM, Mora AM. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. Br J Ophthalmol 2018 103:648–653. Epub 2018/ 07/05. doi::10.1136/bjophthalmol–2018–312072
   Google Scholar
• Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Transfus Apher Sci 2017;56(4): 595–604. Epub 2017/ 08/29. doi: 10.1016/j.transci.2017.07.023
   PubMed Web of Science ®Google Scholar
• Drew VJ, Tseng CL, Seghatchian J, Burnouf T. Reflections on dry eye syndrome treatment: therapeutic role of blood products. Front Med (Lausanne) 2018;5: 33. Epub 2018/ 03/13
   PubMed Web of Science ®Google Scholar
• Hayon Y, Dashevsky O, Shai E, Varon D, Leker RR. Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke. Thromb Haemost 2013;110(8): 323–330. Epub 2013/ 06/15. doi: 10.1160/TH12-11-0875
   PubMedGoogle Scholar
• Chou ML, Wu JW, Gouel F, Jonneaux A, Timmerman K, Renn TY, Laloux C, Chang HM, Lin LT, Devedjian JC, et al. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson’s disease. Biomaterials 2017;142: 77–89. Epub 2017/ 07/21. doi: 10.1016/j.biomaterials.2017.07.018
   PubMed Web of Science ®Google Scholar
• Anitua E, Pascual C, Perez-Gonzalez R, Orive G, Carro E. Intranasal PRGF-endoret enhances neuronal survival and attenuates NF-kappaB-dependent inflammation process in a mouse model of parkinson’s disease. J Control Release 2015;203: 170–180. Epub 2015/ 02/24. doi: 10.1016/j.jconrel.2015.02.030
   PubMed Web of Science ®Google Scholar
• Nebie O, Devos D, Vingtdeux V, Barro L, Devedjian JC, Jonneaux A, Chou ML, Bordet R, Buee L, Knutson F, et al. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. J Biomed Sci 2019;26: 89. Epub 2019/ 11/02. doi: 10.1186/s12929-019-0579-9
   PubMed Web of Science ®Google Scholar
• Anitua E, Pascual C, Perez-Gonzalez R, Antequera D, Padilla S, Orive G, Carro E. Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer’s disease. PLoS One 2013;8: e73118. Epub 2013/ 09/27. doi: 10.1371/journal.pone.0073118
   PubMed Web of Science ®Google Scholar
• Gouel F, Do Van B, Chou ML, Jonneaux A, Moreau C, Bordet R, Burnouf T, Devedjian JC, Devos D. The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways. J Tissue Eng Regen Med 2017;11: 3236–3240. Epub 2016/ 12/13. doi: 10.1002/term.2222
   PubMed Web of Science ®Google Scholar
• Gouel F, Rolland AS, Devedjian JC, Burnouf T, Devos D. Past and Future of neurotrophic growth factors therapies in ALS: from single neurotrophic growth factor to stem cells and human platelet lysates. Front Neurol 2019;10: 835. Epub 2019/ 08/21. doi: 10.3389/fneur.2019.00835
   PubMed Web of Science ®Google Scholar
• Nebie O, Barro L, Wu YW, Knutson F, Buee L, Devos D, Peng CW, Blum D, Burnouf T. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro. Platelets 2020 31;1–12. Epub 2019/11/02
   Google Scholar
• Li H, Hicks JJ, Wang L, Oyster N, Philippon MJ, Hurwitz S, Hogan MV, Huard J. Customized platelet-rich plasma with transforming growth factor β1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials 2016;87: 147–156.
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008;14: 199–215. doi: 10.1089/ten.teb.2007.0435
   PubMed Web of Science ®Google Scholar
• Linnes MP, Ratner BD, Giachelli CM. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007;28(35):5298–5306. doi: 10.1016/j.biomaterials.2007.08.020
   PubMed Web of Science ®Google Scholar
• Piers TM, East E, Villegas-Llerena C, Sevastou IG, Matarin M, Hardy J, Pocock JM. Soluble fibrinogen triggers non-cell autonomous ER stress-mediated microglial-induced neurotoxicity. Front Cell Neurosci 2018;12: 404. doi: 10.3389/fncel.2018.00404
   PubMed Web of Science ®Google Scholar
• Sulimai N, Lominadze D.Fibrinogen and neuroinflammation during traumatic brain Injury. Mol Neurobiol 2020;57(11: 4692–4703. Epub 2020/ 08/11. doi: 10.1007/s12035-020-02012-2
   PubMed Web of Science ®Google Scholar
• Li H, Hicks JJ, Wang L, Oyster N, Philippon MJ, Hurwitz S, Hogan MV, Huard J. Customized platelet-rich plasma with transforming growth factor beta1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials 2016;87: 147–156. Epub 2016/ 03/01. doi: 10.1016/j.biomaterials.2016.02.017
   PubMed Web of Science ®Google Scholar
• Anitua E, Muruzabal F, De la Fuente M, Merayo-Lloves J, Orive G. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. Exp Eye Res 2014;119: 27–34. Epub 2013/ 12/19. doi: 10.1016/j.exer.2013.12.005
   PubMed Web of Science ®Google Scholar
• D’Asta F, Halstead F, Harrison P, Zecchi Orlandini S, Moiemen N, Lord J. The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: A systematic review. Platelets 2018;29(1): 9–20. Epub 2017/ 07/07. doi: 10.1080/09537104.2017.1317731
   PubMed Web of Science ®Google Scholar
• Burnouf T, Chou ML, Wu YW, Su CY, Lee LW. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion 2013;53: 138–146. Epub 2012/ 05/09. doi: 10.1111/j.1537-2995.2012.03668.x
   PubMed Web of Science ®Google Scholar
• van der Pol E, Harrison P. From platelet dust to gold dust: physiological importance and detection of platelet microvesicles. Platelets 2017;28(3): 211–213. Epub 2017/ 05/04. doi: 10.1080/09537104.2017.1282781
   PubMed Web of Science ®Google Scholar
• Goubran HA, Burnouf T, Stakiw J, Seghatchian J. Platelet microparticle: a sensitive physiological “fine tuning” balancing factor in health and disease. Transfus Apher Sci 2015;52(1): 12–18. Epub 2015/ 01/21. doi: 10.1016/j.transci.2014.12.015
   PubMed Web of Science ®Google Scholar
• Torreggiani E, Perut F, Roncuzzi L, Zini N, Baglio SR, Baldini N. Exosomes: novel effectors of human platelet lysate activity. Eur Cell Mater 2014;28: 137–151. discussion 151. Epub 2014/ 09/23. doi: 10.22203/eCM.v028a11
   PubMed Web of Science ®Google Scholar
• Johnson J, Wu YW, Blyth C, Lichtfuss G, Goubran H, Burnouf T. Prospective therapeutic applications of platelet extracellular vesicles. Trends in Biotechnology. Cell press 2020
   Google Scholar
• Harrison P, Alsousou J. Studies on platelet rich plasma - new editorial policy for “Platelets”. Platelets 2020;31(3): 281–282. Epub 2020/ 03/04. doi: 10.1080/09537104.2020.1729013
   PubMed Web of Science ®Google Scholar
• Harrison P. Subcommittee on Platelet P. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost 2018;16(9): 1895–1900. Epub 2018/ 08/14. doi: 10.1111/jth.14223
   PubMed Web of Science ®Google Scholar
• Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 2017;57: 1058–1065. Epub 2017/ 02/10
   PubMed Web of Science ®Google Scholar
• Wang TJ, Chen MS, Chou ML, Lin HC, Seghatchian J, Burnouf T. Comparison of three human platelet lysates used as supplements for in vitro expansion of corneal endothelium cells. Transfus Apher Sci 2017;56: 769–773. Epub 2017/ 09/25. doi: 10.1016/j.transci.2017.08.021
   PubMed Web of Science ®Google Scholar
• Barro L, Su YT, Nebie O, Wu YW, Huang YH, Koh MB, Knutson F, Burnouf T. A double-virally-inactivated (Intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells. Transfusion 2019;59: 2061–2073. Epub 2019/ 03/27
   PubMed Web of Science ®Google Scholar
• Burnouf T, Tseng YH, Kuo YP, Su CY. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Transfusion 2008 48: 1090–1098
   PubMed Web of Science ®Google Scholar
• Chen MS, Wang TJ, Lin HC, Burnouf T. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells. N Biotechnol 2019;49: 151–160. Epub 2018/ 11/23
   PubMed Web of Science ®Google Scholar
• Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(Suppl 1):S13–33. Epub 2011/ 04/12
   PubMed Web of Science ®Google Scholar
• Zamani M, Yaghoubi Y, Movassaghpour A, Shakouri K, Mehdizadeh A, Pishgahi A, Yousefi M. Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: are we ready for clinical use? J Cell Physiol 2019;234(10): 17172–17186. Epub 2019/ 03/27. doi: 10.1002/jcp.28496
   PubMed Web of Science ®Google Scholar
• Le AD, Enweze L, DeBaun MR, Dragoo JL. Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med 2018;11: 624–634. doi: 10.1007/s12178-018-9527-7
   PubMed Web of Science ®Google Scholar
• Bieback K. Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfusion Med Hemother 2013;40(5):326–335. doi: 10.1159/000354061
   PubMed Web of Science ®Google Scholar
• Moroz A, Bittencourt RAC, Almeida RP, Felisbino SL, Deffune E. Platelet lysate 3D scaffold supports mesenchymal stem cell chondrogenesis: an improved approach in cartilage tissue engineering. Platelets 2013;24: 219–225. doi: 10.3109/09537104.2012.686255
   PubMed Web of Science ®Google Scholar
• Jooybar E, Abdekhodaie MJ, Karperien M, Mousavi A, Alvi M, Dijkstra PJ. Developing hyaluronic acid microgels for sustained delivery of platelet lysate for tissue engineering applications. Int J Biol Macromol 2020;144: 837–846. doi: 10.1016/j.ijbiomac.2019.10.036
   PubMed Web of Science ®Google Scholar
• Perut F, Filardo G, Mariani E, Cenacchi A, Pratelli L, Devescovi V, Kon E, Marcacci M, Facchini A, Baldini N, et al. Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. Cytotherapy 2013;15(7): 830–839. Epub 2013/ 06/05. doi: 10.1016/j.jcyt.2013.01.220
   PubMed Web of Science ®Google Scholar
• Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A, Grigolo B, Kon E, Mariani E, Pratelli L. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014;2014: 1–10. doi: 10.1155/2014/692913
   Web of Science ®Google Scholar
• Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 2006; 38:174
   PubMedGoogle Scholar
• Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofacial Surg 1997;55(11):1294–1299. doi: 10.1016/S0278-2391(97)90187-7
   PubMed Web of Science ®Google Scholar
• Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J ExtraCorporeal Technol 2004; 36:28–35
   Google Scholar
• Huber SC, Cunha Junior JL, Montalvao S, da Silva LQ, Paffaro AU, da Silva FA, Rodrigues BL, Lana JF, Annichino-Bizzacchi JM. In vitro study of the role of thrombin in platelet rich plasma (PRP) preparation: utility for gel formation and impact in growth factors release. J Stem Cells Regen Med 2016;12: 2–9. Epub 2016/ 07/12
   PubMed Web of Science ®Google Scholar
• Giannaccare G, Pellegrini M, Bernabei F, Scorcia V, Campos E. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefe's Archive for Clinical and Experimental Ophthalmology (2019) 257:1341–1351
   Google Scholar
• Chou ML, Burnouf T, Wang TJ. Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet release. PLoS One 2014;9: e99145. Epub 2014/ 06/20. doi: 10.1371/journal.pone.0099145
   PubMed Web of Science ®Google Scholar
• Le Borgne S, Graber M. Amidase activity and thermal stability of human thrombin. Applied biochemistry and biotechnology 1994 48: 125–135 2 doi:10.1007/BF02796167
   PubMed Web of Science ®Google Scholar
• Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets 2013;24: 173–182. Epub 2012/ 06/01
   PubMed Web of Science ®Google Scholar
• Opneja A, Kapoor S, Stavrou EX. Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing. Thromb Res 2019;179: 56–63. Epub 2019/ 05/12. doi: 10.1016/j.thromres.2019.05.001
   PubMed Web of Science ®Google Scholar
• Cortes-Canteli M, Mattei L, Richards AT, Norris EH, Strickland S. Fibrin deposited in the Alzheimer’s disease brain promotes neuronal degeneration. Neurobiol Aging 2015;36: 608–617. Epub 2014/ 12/06. doi: 10.1016/j.neurobiolaging.2014.10.030
   PubMed Web of Science ®Google Scholar
• Ramsby M, Kreutzer D. Fibrin induction of thrombospondin in corneal endothelial cells in vitro. Investigative ophthalmology & visual science 1993 34: 165–174
   PubMed Web of Science ®Google Scholar
• Chou ML, Lin LT, Devos D, Burnouf T. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion 2015;55: 2433–2444. Epub 2015/ 05/20. doi: 10.1111/trf.13162
   PubMed Web of Science ®Google Scholar
• Etscheid M, Breitner‐Ruddock S, Gross S, Hunfeld A, Seitz R, Dodt J. Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products. Vox Sang 2012;102: 40–46. doi: 10.1111/j.1423-0410.2011.01502.x
   PubMed Web of Science ®Google Scholar
• Germishuizen WA, Gyure DC, Stubbings D, Burnouf T. Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products. Biologicals 2014;42: 260–270. Epub 2014/ 08/07. doi: 10.1016/j.biologicals.2014.04.002
   PubMed Web of Science ®Google Scholar
• Mattler L, Bang N. Serine protease specificity for peptide chromogenic substrates. Thromb Haemost 1977;38: 0776–0792. doi: 10.1055/s-0038-1651897
   PubMed Web of Science ®Google Scholar
• Laroche M, Dunois C, Vissac AM, Amiral J. Update on functional and genetic laboratory assays for the detection of platelet microvesicles. Platelets 2017;28: 235–241. doi: 10.1080/09537104.2016.1265925
   PubMed Web of Science ®Google Scholar
• Amiral J, Seghatchian J. The diagnostic usefulness of capture assays for measuring global/specific extracellular micro-particles in plasma. Transfus Apher Sci 2015;53: 127–136. Epub 2015/ 11/18. doi: 10.1016/j.transci.2015.10.009
   PubMed Web of Science ®Google Scholar
• Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004;10: 1611–1626. doi: 10.2174/1381612043384664
   PubMed Web of Science ®Google Scholar
• Plantier JL, Duretz V, Devos V, Urbain R, Jorieux S. Comparison of antioxidant properties of different therapeutic albumin preparations. Biologicals 2016;44: 226–233. Epub 2016/ 05/09. doi: 10.1016/j.biologicals.2016.04.002
   PubMed Web of Science ®Google Scholar
• Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res 2010;20: 34–50. doi: 10.1038/cr.2009.139
   PubMed Web of Science ®Google Scholar
• Middleton O, Wheadon H, Michie A Classical complement pathway. 2016.
   Google Scholar
• Kayser W, Mueller‐Eckhardt C, Bhakdi S, Ebert K. Platelet‐associated Platelet-associated complement C3 in thrombocytopenic states. British journal of haematology 1983 54: 353–363
   PubMed Web of Science ®Google Scholar
• Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. The complement cascade: yin-Yang in neuroinflammation–neuro-protection and -degeneration. J Neurochem 2008;107: 1169–1187. Epub 2008/ 09/13. doi: 10.1111/j.1471-4159.2008.05668.x
   PubMed Web of Science ®Google Scholar
• Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere C. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Science translational medicine 2017;9 (392)
   Web of Science ®Google Scholar
• Bhat SA, Goel R, Shukla R, Hanif K. Platelet CD40L induces activation of astrocytes and microglia in hypertension. Brain Behav Immun 2017;59: 173–189. Epub 2016/ 09/24. doi: 10.1016/j.bbi.2016.09.021
   PubMed Web of Science ®Google Scholar
• García-Culebras A, Durán-Laforet V, Peña-Martínez C, Ballesteros I, Pradillo JM, Díaz-Guzmán J, Lizasoain I, Moro MA. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions. Journal of Cerebral Blood Flow & Metabolism 2018 38: 2150–2164
   PubMed Web of Science ®Google Scholar
• Machovich R, Arányi PJT. haemostasis. Effect of calcium ion on the interaction between thrombin and heparin. Therm Denaturation 1977; 38:0677–0684
   Google Scholar
• Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 2000;41: 1063–1069. Epub 2001/ 02/07
   PubMed Web of Science ®Google Scholar
• Kao WW, Kao CW, Kaufman AH, Kombrinck KW, Converse RL, Good WV, Bugge TH, Degen JL. Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice. Invest Ophthalmol Vis Sci 1998;39: 502–508. Epub 1998/ 03/21
   PubMed Web of Science ®Google Scholar
• Chen TM, Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatologic Surgery 2010 36: 453–460
   PubMed Web of Science ®Google Scholar
• Somani A, Rai R. Comparison of efficacy of autologous platelet-rich fibrin versus saline dressing in chronic venous leg ulcers: A randomised controlled trial. Journal of cutaneous and aesthetic surgery 2017 10: 8 1 doi:10.4103/JCAS.JCAS_137_16
   PubMedGoogle Scholar
• Kljenak A, Tominac Trcin M, Bujić M, Dolenec T, Jevak M, Mršić G, Zmiš G, Barčot Z, Muljačić A , Popović M. Fibrin gel as a scaffold for skin substitute–production and clinical experience. Acta Clinica Croatica 2016 55: 279–288 doi:10.20471/acc.2016.55.02.15
   Google Scholar
• Owens AP III, Mackman N. Microparticles in hemostasis and thrombosis. Circulation research 2011 108: 1284–1297
   PubMed Web of Science ®Google Scholar
• Bevers EM, Williamson P L.. Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. Physiological reviews 2016 96: 605–645 2 doi:10.1152/physrev.00020.2015
   PubMed Web of Science ®Google Scholar
• Morel O, Morel N, Freyssinet J-M, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008 19: 9–23
   Google Scholar
• Arakelyan A, Fitzgerald W, Vagida M, Vasilieva E, Margolis L, Grivel J-C. Addition of thrombin reduces the recovery of extracellular vesicles from blood plasma. Journal of Circulating Biomarkers 2016;5: 1849454416663648. Epub 2017/ 09/25. doi: 10.1177/1849454416663648
   Google Scholar
• Mann K, Brummel K, Butenas S. What is all that thrombin for?. Journal of Thrombosis and Haemostasis 2003 1: 1504–1514
   PubMed Web of Science ®Google Scholar
• Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutrition Journal 2015;15(1):1–22
   Web of Science ®Google Scholar
• Sthijns MM, van Blitterswijk CA. LaPointe VL. Redox regulation in regenerative medicine and tissue engineering: the paradox of oxygen. Journal of tissue engineering and regenerative medicine 2018 12: 2013–2020
   Google Scholar
• Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004;3(3):205–214. doi: 10.1038/nrd1330
   PubMed Web of Science ®Google Scholar
• Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862(4):576–591. doi: 10.1016/j.bbadis.2016.01.003
   PubMed Web of Science ®Google Scholar
• Ung L, Pattamatta U, Carnt N, Wilkinson-Berka JL, Liew G, White AJ. Oxidative stress and reactive oxygen species: a review of their role in ocular disease. Clin Sci 2017; 131:2865–2883
   PubMed Web of Science ®Google Scholar
• Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS letters 2008 582: 1783–1787
   PubMed Web of Science ®Google Scholar
• Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radical Biology and Medicine 2013 65: 244–253
   Google Scholar
• Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H. Profiles of antioxidants in human plasma. Free Radical Biology and Medicine 2001 30: 456–462
   PubMed Web of Science ®Google Scholar